Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease (Q30725675)

26 June 2017

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease (English)

1 reference

26 June 2017

1 reference

4

Robert D Moir

0 references

Julien Muffat

Julien A Muffat

2

0 references

Lee E Goldstein

Lee E Goldstein

1

0 references

Ashley I. Bush

Ashley I Bush

14

0 references

Colin L. Masters

11

Colin L Masters

1 reference

26 June 2017

12

Rudolph E Tanzi

1 reference

26 June 2017

7

Christine Mavros

1 reference

26 June 2017

Robert A Cherny

3

1 reference

26 June 2017

Maria H Ericsson

5

1 reference

26 June 2017

Xudong Huang

6

1 reference

26 June 2017

Jennifer A Coccia

8

1 reference

26 June 2017

Kyle Y Faget

9

1 reference

26 June 2017

Karlotta A Fitch

10

1 reference

26 June 2017

Leo T Chylack

13

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

26 June 2017

1 reference

26 June 2017

361

1 reference

26 June 2017

1258-1265

1 reference

26 June 2017

9365

1 reference

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

New frontiers in Alzheimer's disease genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

The eyes in mongolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

The function of alpha-crystallin in vision

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Interaction between beta-amyloid and lens alphaB-crystallin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Interaction of intracellular beta amyloid peptide with chaperone proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Alzheimer disease and cataract: common threads.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Specific metal-catalysed protein oxidation reactions in chronic degenerative disorders of ageing: focus on Alzheimer's disease and age-related cataracts.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Intraneuronal Abeta42 accumulation in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

Theory of transparency of the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

A quantitative analysis of transparency in the human sclera and cornea using Fourier methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912981-9

7 January 2021

10.1016/S0140-6736(03)12981-9

Identifiers

DOI

1 reference

26 June 2017

1 reference